M.D. Sass LLC’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-796,776
Closed -$18.2M 30
2022
Q1
$18.2M Sell
796,776
-272,001
-25% -$6.65M 3.12% 19
2021
Q4
$29.5M Buy
1,068,777
+42,361
+4% +$1.13M 4.58% 9
2021
Q3
$28.6M Buy
1,026,416
+191,698
+23% +$5.44M 4.86% 7
2021
Q2
$24.5M Buy
834,718
+117,759
+16% +$3.57M 4.05% 10
2021
Q1
$22.8M Sell
716,959
-410,909
-36% -$12.1M 4% 15
2020
Q4
$23.5M Buy
1,127,868
+117,876
+12% +$2.2M 5.03% 8
2020
Q3
$15.7M Buy
1,009,992
+96,902
+11% +$1.67M 3.89% 11
2020
Q2
$16.7M Buy
913,090
+429,953
+89% +$7.58M 4.43% 6
2020
Q1
$7.49M Buy
483,137
+67,698
+16% +$1.63M 2.72% 23
2019
Q4
$12.4M Sell
415,439
-236,244
-36% -$6.14M 2.94% 19
2019
Q3
$14.2M Buy
651,683
+62,102
+11% +$1.42M 3.36% 9
2019
Q2
$14.9M Sell
589,581
-421,017
-42% -$10M 3.44% 11
2019
Q1
$25M Buy
1,010,598
+115,750
+13% +$2.76M 3.98% 8
2018
Q4
$16.5M Buy
894,848
+825,048
+1,182% +$19.6M 2.81% 21
2018
Q3
$1.79M Buy
+69,800
New +$1.6M 0.24% 38

Other funds holding BHC

M.D. Sass LLC's BHC Position: Q2 2022 in Review

M.D. Sass LLC sold out of Bausch Health (BHC) in Q2 2022, closing a stake of 796,776 shares — an estimated $18.2M sold.

M.D. Sass LLC first reported a position in BHC in Q3 2018 and held it in 15 quarters. The position peaked at $29.5M in Q4 2021. 327 funds tracked by Wall St. Rank hold BHC as of Q2 2022.

  • M.D. Sass LLC reported no remaining Bausch Health position as of Q2 2022 after selling out during the quarter.
  • M.D. Sass LLC sold 796,776 Bausch Health shares in Q2 2022, an estimated $18.2M.
  • M.D. Sass LLC first reported a position in Bausch Health in Q3 2018 and held it in 15 quarters.
  • M.D. Sass LLC's Bausch Health position peaked at $29.5M in Q4 2021.
  • 327 funds tracked by Wall St. Rank held Bausch Health as of Q2 2022.

Based on M.D. Sass LLC's 13F filing for Q2 2022, filed 15 Aug 2022.